Carlo Incerti's most recent trade in Dyne Therapeutics Inc was a trade of 35,000 Stock option (right to buy) done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.69 per share. | 18 Nov 2024 | 16,500 | 16,500 | - | 8.7 | 143,385 | Common Stock |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 16,500 | 22,693 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Sale of securities on an exchange or to another person at price $ 28.73 per share. | 18 Nov 2024 | 16,500 | 0 | - | 28.7 | 474,045 | Common Stock |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 25,133 | 25,133 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Carlo Incerti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 24,900 | 24,900 | - | - | Stock Option (right to buy) |